Questions to Ask a Telehealth Platform Vendor Before You Sign

A strong telehealth vendor evaluation should produce written answers—not just a polished demo. Ask each vendor to document licensing coverage, clinical-workflow responsibilities, pharmacy and fulfillment dependencies, HIPAA contracting, data ownership and export, pricing variables, security controls, and what happens to patient records if the relationship ends.

Requirements at a glance

Start with a consistent evaluation framework

Use the same questions, scoring scale, and requested evidence for every platform. Compliance responsibility, data control, and operational continuity generally deserve more weight than visual polish or a long feature list.

A vendor that cannot explain state coverage or data export should not receive the same assessment as one that supplies complete contractual answers.

Questions to ask before you sign

These telehealth platform RFP questions can be copied into a vendor email. Require written answers and ask the vendor to identify any item handled by your medical group, an affiliated clinical entity, a pharmacy, a payment processor, or another subcontractor.

What should you ask about licensing and geographic operations?

1. 1Which states can your platform support today, and what does “support” mean in each state? Identify software controls, clinician-licensure assumptions, patient-location requirements, prescribing limitations, and responsibilities that remain with our medical group.
2. 2How do you verify clinician licenses, compact privileges, prescribing authority, and expiration dates? Who is responsible when a state rule changes?
3. 3How does the system determine and record the patient’s location? Can it block or route a visit when the patient is outside the clinician’s authorized jurisdiction?
4. 4Which clinical decisions remain exclusively with independently licensed clinicians rather than with your platform, staff, or business brand?

State coverage should not be accepted as a single “nationwide” checkbox. State medical, nursing, pharmacy, and other professional boards may impose requirements separate from the platform’s technical capabilities. Federal materials do not replace a state-by-state review.

What should you ask about pharmacy and fulfillment connectivity?

1. 1Which pharmacy, e-prescribing, eligibility, benefits, fulfillment, and processor relationships are part of the proposed workflow? Identify optional and third-party services.
2. 2Can our practice choose or change pharmacy and fulfillment partners? What happens when a pharmacy rejects, cannot fill, or cannot receive an electronic prescription?
3. 3Which records can we export if we leave, including prescription-related status, reconciliation records, and audit history?

Request a written network and dependency map rather than accepting “pharmacy access” as a complete description. The answer should distinguish connectivity from fulfillment and identify who controls each handoff. This article does not address medication sourcing, dosing, administration, or patient-use instructions.

What should you ask about data, privacy, and security?

1. 1Will you sign our business associate agreement before production access to electronic protected health information? Which entities or subcontractors will handle that information?
2. 2Who owns patient records, messages, images, forms, recordings, audit logs, billing history, operational data, metadata, and derived analytics? What license do you claim to use them?
3. 3Can we prohibit use of our data for model training, benchmarking, marketing, or product improvement? Do restrictions apply to subcontractors?
4. 4What export formats are available? Can we receive a sample export containing attachments, consent records, audit logs, and other required records before signing?
5. 5What are your encryption, access-control, administrative logging, backup, recovery, uptime, and incident-notification commitments? What evidence can we review for our own risk analysis?

HHS explains that a cloud provider may be a HIPAA business associate even when it stores only encrypted electronic protected health information and cannot decrypt it. A “HIPAA compliant” marketing label is not a substitute for role mapping, a BAA where required, contract review, and your own risk analysis. Certain health apps and similar products may also implicate the FTC Health Breach Notification Rule, depending on their activities.

What should you ask about pricing and exit terms?

1. 1What fees are based on clinicians, locations, visits, messages, patients, transactions, storage, claims, prescriptions, integrations, or API usage? Which costs are passed through from third parties?
2. 2Can pricing change during the initial term or at renewal? What notice, minimums, volume commitments, overage rates, and auto-renewal terms apply?
3. 3Who is the merchant of record for patient payments? Which party issues receipts and handles refunds or disputes?
4. 4What happens to patient access, scheduling, messaging, records, and read-only access after termination? How long is an export available?
5. 5What notice applies to termination for convenience? Are there termination rights for repeated downtime, security incidents, regulatory changes, or material service failures?
6. 6Does the agreement contain exclusivity, non-compete, customer-solicitation, or restrictions on using another platform during transition?

How should you use the answers?

1. 1Send identical questions to each vendor.
2. 2Separate a verbal assurance from a contractual commitment.
3. 3Request the BAA, service-level terms, data-processing terms, pricing schedule, subcontractor disclosures, and exit procedure before approval.
4. 4Test a sample data export and map who performs each clinical, pharmacy, payment, and compliance task.
5. 5Have qualified legal, privacy, compliance, and clinical reviewers assess unresolved issues.
6. 6Record open items, owners, deadlines, and the consequence if an answer changes.

Which vendor answers are red flags?

• “We cover every state” without a written responsibility matrix. The claim may conceal assumptions about clinician licensing, patient location, prescribing, registration, or state-specific workflows.
• A refusal to sign a BAA when the vendor handles PHI on the practice’s behalf. Role and access—not a marketing label—are central to the analysis.
• “You own your data” with no export format, timing, attachment coverage, backup treatment, or deletion process. Ownership without portability may leave the practice dependent on the vendor.
• Unrestricted secondary use of patient data or derived data. Understand and negotiate permitted uses rather than relying on a demo conversation.
• Pricing that excludes material implementation, integration, transaction, pharmacy, payment, storage, or exit charges. Undefined utilization assumptions can distort the quote.
• No plan for downtime, security incidents, acquisition, insolvency, or product discontinuation. Continuity is a business requirement.
• Time-sensitive prescribing claims presented as permanent capability. DEA and HHS telemedicine flexibilities described in the research packet run through December 31, 2026, subject to their conditions and other law.

What commercial terms do buyers often miss?

The consequential terms are often outside the headline subscription price. Confirm who controls and may use patient data; whether exports are machine-readable; whether attachments, logs, consents, and billing records are included; and how long records remain accessible after termination.

Check notice periods for convenience termination, suspension, renewal, and price changes. Look for automatic renewals, minimum commitments, implementation charges, migration assistance fees, and restrictions on using another platform. Identify the merchant of record before launch; the platform, medical group, pharmacy, and payment processor may be separate entities.

Reimbursement claims also require precision. CMS maintains a Medicare telehealth services list and updates it through the annual physician fee schedule process. Ask the vendor to identify the payer, service, clinician type, location rule, and date supporting any statement that a workflow is “covered.” Medicare rules do not establish commercial, employer-plan, or state Medicaid access.

Why these questions matter

A general telehealth review may focus on video quality, scheduling, messaging, and patient experience. A vendor evaluation also tests boundaries: who is responsible when a patient crosses a state line, a clinician’s authorization changes, a pharmacy rejects a transaction, a payer rule changes, or the business exits?

MDLaunchr’s role in your comparison

MDLaunchr is one of the platforms in the white-label telehealth infrastructure category; this article is not a ranked vendor review. Apply the same questions to MDLaunchr and every other platform under consideration. MDLaunchr is the brand behind WhiteLabelClinic.com, designed to help qualified businesses evaluate and coordinate technology, operational, compliance, clinical-network, and fulfillment relationships involved in launching telehealth services.

Compare platform options for your medical business

Are a platform’s prescribing capabilities permanent?

No. Prescribing workflows depend on the platform’s role, clinician authority, pharmacy relationships, and changing federal and state requirements. Treat time-sensitive claims as requiring dated source documentation and regulatory review.

Related reading: How to Choose the Best Telehealth Platform for Creators, How to Choose the Best Telehealth Platform for a Practice.